STOCK TITAN

Precision Optics Corporation, Inc. - POCI STOCK NEWS

Welcome to our dedicated page for Precision Optics Corporation news (Ticker: POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics Corporation stock.

Precision Optics Corporation, Inc. (NASDAQ: POCI) is a leading designer and manufacturer of cutting-edge optical instruments, primarily serving the medical, defense, and aerospace industries. Founded in 1982, this Gardner, Massachusetts-based company has cemented its place in the market by leveraging its proprietary micro-optics and advanced 3D imaging technologies.

Core Business: Precision Optics specializes in developing and manufacturing high-quality optical medical devices, including endoscopes and endocouplers, which are crucial for minimally invasive surgical and diagnostic procedures. The company is also known for designing custom optical solutions tailored to meet specific client needs in the medical, industrial, and military sectors.

Recent Achievements: On December 4, 2023, the company announced a significant production and technology license agreement with a leading surgical robotics firm. This agreement involves the supply of a single-use endoscope assembly for cystoscopy robotic surgery systems, a project that emerged from joint developmental efforts over the past 18 months.

Current Projects: Precision Optics is gearing up for the mass production of the single-use endoscope assembly, expected to start within six to twelve months. This new venture aligns with the company's strategic push into the rapidly growing single-use medical device market, a segment experiencing higher growth rates compared to the broader medical device sector.

Financial Condition: The company's latest financial results for Q2 of fiscal year 2024 indicate steady progress. Despite some fluctuations in revenue due to timing differences and new program rollouts, Precision Optics reported a 12% increase in total revenue compared to the previous quarter, driven by record engineering revenue and new production programs.

Partnerships: The company continues to forge strong partnerships within the medical and defense industries. These collaborations are facilitated by Precision Optics' in-house capabilities in design, prototyping, regulatory compliance, and mass manufacturing, supported by its Lighthouse Imaging and Ross Optical divisions.

Products: Within the healthcare sector, Precision Optics focuses on next-generation medical devices, including single-use instruments and 3D endoscopy systems. The company also extends its expertise to the defense and aerospace sectors, delivering high-quality optical components that meet rigorous standards for size, weight, and power optimization.

For more information, please visit www.poci.com.

Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced the receipt of initial purchase orders towards a $1.4 million total program development project to develop a highly complex imaging sub-assembly for a next generation ophthalmoscope for a major medical device company. The initial purchase orders amount to $170,000 towards the development budget and the program is expected to move to initial production in 18 months. The new device aims to improve access to high-quality retinal exams, crucial for early detection of diabetic retinopathy and other treatable retina-based conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
none
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced unaudited Q1 2024 operating results, revealing a 15% revenue decrease to $4.3 million. The company also reported a net loss of ($464,415) and an adjusted EBITDA of ($244,983) for the quarter. Recent highlights include a $890,000 production order for a new robotic laparoscopy system and a $680,000 production order for a defense/aerospace application.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced an $890,000 initial production order for a complex imaging sub-assembly for a new robotic laparoscopy system. The order is expected to be delivered between January and October 2024, with potential for follow-on orders depending on market acceptance. This development is anticipated to drive revenue growth and recovery in the second half of the fiscal year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
none
Rhea-AI Summary
Precision Optics Corporation, Inc. (Nasdaq: POCI) to Discuss Q1 2024 Financial Results in Upcoming Conference Call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.51%
Tags
-
Rhea-AI Summary
Precision Optics Corporation announces $680,000 of initial production orders from a defense/aerospace company for a new commercial application.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.55%
Tags
none
-
Rhea-AI Summary
Precision Optics Corporation to present at Lytham Partners Fall 2023 Investor Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
conferences
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced its unaudited operating results for Q4 and fiscal year 2023. Revenue increased by 34% to $21.0 million compared to the previous year. Gross margin improved to 36.8% from 31.4% in the previous year. Adjusted EBITDA reached a record $491,219 compared to $(242,293) in the previous year. However, there was a net loss of ($144,613) compared to a net loss of ($928,416) in the previous year. Q4 revenue increased by 5% to $5.02 million. Gross margin improved to 38.5% from 30.1% in the same quarter of the previous year. Net loss for the quarter was ($96,125) compared to net income of $269,293 in the same quarter of the previous year. Adjusted EBITDA was $(412,026) for the quarter. The company also highlighted significant product development orders and investments in its management team. CEO Joseph Forkey expressed optimism for accelerated growth in the second half of fiscal 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
-
Rhea-AI Summary
Precision Optics Corporation schedules conference call to discuss Q4 and FY2023 financial results on September 28, 2023 at 5:00pm ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.09%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.55%
Tags
none

FAQ

What is the current stock price of Precision Optics Corporation (POCI)?

The current stock price of Precision Optics Corporation (POCI) is $5.21 as of December 20, 2024.

What is the market cap of Precision Optics Corporation (POCI)?

The market cap of Precision Optics Corporation (POCI) is approximately 32.7M.

What does Precision Optics Corporation, Inc. specialize in?

Precision Optics Corporation specializes in designing, developing, and manufacturing advanced optical instruments, particularly for the medical, defense, and aerospace industries.

What are some of the key products offered by Precision Optics?

The company offers endoscopes, endocouplers, and custom optical medical devices, as well as components designed for industrial and military use.

What recent achievements has Precision Optics Corporation announced?

Recently, the company signed a production and technology license agreement with a leading surgical robotics firm for a single-use endoscope assembly used in cystoscopy robotic surgery.

What sectors does Precision Optics serve?

Precision Optics serves the medical, defense, and aerospace sectors, supplying advanced optical instruments and components.

What are the company's recent financial highlights?

For Q2 of fiscal year 2024, the company reported a 12% increase in total revenue compared to the previous quarter, driven by new production programs and record engineering revenue.

Who are Precision Optics' partners?

The company partners with leading firms in the medical, defense, and aerospace industries, leveraging its in-house capabilities and divisions like Lighthouse Imaging and Ross Optical.

When was Precision Optics Corporation founded?

Precision Optics Corporation was founded in 1982.

Where is Precision Optics Corporation headquartered?

The company is headquartered in Gardner, Massachusetts.

What is the focus of Precision Optics in the medical device market?

The focus is on developing next-generation medical devices, including single-use instruments and 3D endoscopy systems, to meet the increasing demands of minimally invasive surgeries.

How can I learn more about Precision Optics Corporation?

For more information, you can visit their website at www.poci.com.

Precision Optics Corporation, Inc.

Nasdaq:POCI

POCI Rankings

POCI Stock Data

32.74M
4.85M
24.86%
32.15%
0.07%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
GARDNER